Showing results (211-220 of 241) with videos related to
Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|May 13, 2015
Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotypeRosmarie Gaupp, Shulei Lei, Joseph M Reed, et al.Pediatrics|February 17, 2017
Daptomycin for Complicated Skin Infections: A Randomized TrialJohn Bradley, Chad Glasser, Hernando Patino, et al.Critical Care (London, England)|April 27, 2018
Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortalityJared A Greenberg, Cara L Hrusch, Mohammad R Jaffery, et al.The Journal of Pediatrics|March 1, 1981
Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type bR S Daum, M P Glode, D A Goldmann, et al.Vaccine|January 1, 1993
Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster dosesG B Calandra, L J Lukacs, L C Jonas, et al.Journal of Clinical Microbiology|June 25, 2014
Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detaineesMichael Z David, Jane D Siegel, Janet Henderson, et al.International Journal of Cancer|February 20, 1991
Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P-glycoprotein): determination of P-glycoprotein expression in multi-drug-resistant KB and CEM cell variantsC Cenciarelli, S J Currier, M C Willingham, et al.The New England Journal of Medicine|December 18, 1986
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccineD M Granoff, P G Shackelford, B K Suarez, et al.Annals of Surgery|February 11, 2017
Can Methicillin-resistant Staphylococcus aureus Silently Travel From the Gut to the Wound and Cause Postoperative Infection? Modeling the "Trojan Horse Hypothesis"Monika A Krezalek, Sanjiv Hyoju, Alexander Zaborin, et al.Oncotarget|March 5, 2016
Insights from HuR biology point to potential improvement for second-line ovarian cancer therapyYu-Hung Huang, Weidan Peng, Narumi Furuuchi, et al.Pageof 25